What this study is
This study is being done to see the long-term results for patients who choose to have surgery for lymphedema (with the vascularized lymph node transfer), compared to patients who choose not to have surgery.
What's being tested
- Quality of Life Assessments
Intervention · BEHAVIORAL
Upper Limb Lymphedema (ULL-27), Lymphedema Life Impact Scale, version 2 (LLISv2), LYMQOL-Leg.
Study details
- Official title
- A Prospective Study Comparing Quality of Life in Patients With Lymphedema Who Undergo Surgical Treatment Versus Non-Surgical Management
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Conditions
- Lymphedema
- Enrolling
- 600 people
- Starts
- 2017-08-09
- Est. completion
- 2027-08
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years – 80 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- Patients aged 18-80 years
- Primary and secondary lymphedema of the upper or lower extremity
- International Society of Lymphology (ISL) Stage 1, 2, or 3 lymphedema
- Proficiency in English language
You can't join if
- Patients with clotting disorders, venous insufficiency, end-stage lymphedema unless they are on the non-surgical arm.
- Additionally, if the patient refuses to complete questionnaires, the patient will be excluded from the study and replaced at the discretion of the principal or co-principal investigator.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (3)
3 openContact for every open site
- Babak Mahrara, MD · Contact646-608-8085
Contact for 2 of 3 open sites
- Andrea Barrio, MD · Contact646-888-5118
Memorial Sloan Kettering Westchester (Limited Protocol Activities)
Harrison, New York, United States
RecruitingMemorial Sloan Kettering Cancer Center
New York, New York, United States
RecruitingMemorial Sloan Kettering Nassau (Limited Protocol Activites)
Rockville Centre, New York, United States
Recruiting
Study team
Sponsor
Memorial Sloan Kettering Cancer Center
Study ID 17-377
Principal investigator
Babak Mahrara, MD
Memorial Sloan Kettering Cancer Center
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.